GLYCEMIC CONTROL IN DIABETES TYPE 2 PATIENTS BY METFORMIN AND OTHER SULFONYLUREAS
Journal Title: European Journal of Pharmaceutical and Medical Research - Year 2018, Vol 5, Issue 1
Abstract
Background: Diabetes mellitus (DM) is a prevalent disorder worldwide, characterized by elevated serum glucose levels and a constellation of symptoms including polydipsia, polyuria and fluctuations in weight. The mainstay of treatment for DM depends greatly on the A1C levels. A1C levels measure the average blood glucose level over the past two to three months. In order to prevent progression of DM patients are treated with lifestyle modifications and a combination of pharmacological agents to achieve long term glycemic control. One such combination includes Metformin and an oral antihyperglycemic agent such as Sulfonylureas. This combination of medications will be the focus of this study on patients with Type 2 Diabetes (T2DM). Objective: The objective of this study is to evaluate the effectiveness of a combination of sulfonylurea and metformin on glycemic control in patients with Type 2 Diabetes Mellitus. Methods: A cross-sectional study design was adopted using a convenient sampling technique during a one month period from June to August, 2017. A sample size of 100 patients was studied and data was collected from two major hospitals in Lahore, Pakistan. A data collection form was designed and was filled during face to face interviews with the patients, and physicians. Data was presented as a percentage. Results: The study showed that 80% of the patients were prescribed metformin, 20% sulfonylureas. 90% patients have performed their HbA1c. Conclusion: Type II diabetes is a common disease prevailing throughout the world. Type II diabetes is also associated with several other metabolic abnormalities. The main pathologic defects in diabetes consist of excessive hepatic glucose production, peripheral insulin resistance and defective beta-cell secretory function. Metformin improves glycemic control by reducing hepatic glucose production, increasing insulin sensitivity, and reducing intestinal glucose absorption, without increasing insulin secretion. Sulfonylureas prefer for metabolic abnormalities by reducing hypoglycemia.
Authors and Affiliations
Sombel Mazhar
Keywords
Related Articles
- EP ID EP634984
- DOI -
- Views 114
- Downloads 0
ROLE OF IABP IN CLINICAL PRACTICE: A REVIEW
Last few decades IABP is widely used for mechanical circulatory support which increases oxygen supply and reducing oxygen demand, works on the principles of diastolic inflation and systolic deflation of balloon. IABP is...
INTRANASAL MIDAZOLAM, FENTANYL AND DEXMEDITOMITIDINE AS A PREMEDICATION IN PEDIATRIC SURGICAL PATIENTS
Background: For providing premedication to pediatric surgical patients, various drugs and many routes have been studied. Intranasal route is one of them. It’s one of the preferred routes because of the ease of administra...
A CROSS SECTIONAL STUDY OF KNOWLEDGE, ATTITUDE AND PRACTICES OF MENSTRUAL HYGIENE AMONGAU FEMALE STUDENTS
Menstruation and menstrual practices are associated with taboos and socio-cultural restrictions. Good hygienic practices such as the use of sanitary pads and adequate washing of genital area are essential during menstrua...
THE OPINION AND ATTITUDE ABOUT CUPPING THERAPY AMONG GENERAL POPULATION OF NORTHERN REGION OF SAUDI ARABIA
Objectives of the study: The primary objective was to assess the opinion and attitude about cupping therapy among general population of Saudi Arabia and secondary objective was to assess prevalence and causes of cupping...
THE EFFECT OF HEAT ON OSSEOINTEGRATION IN TWO STEPS DENTAL IMPLANT.
A dental implant is a device of biocompatible material placed within or against the bone to provide additional or enhanced support for a prosthesis. when placed in a suitably prepared site with in the bone, could become...